Medical Account Specialist II - Oncology - Fresno, CA
Regeneron Pharmaceuticals
Summary
The Oncology Account Specialist will engage HCPs who treat NSCLC/NMSC patients within specific accounts - including academic centers, large group practices, IDN's, and community accounts. This key role will focus on presenting clinically focused selling messages to build and grow revenue and to consistently deliver product goals.
Job description
Discover your role
- Engage Oncology Specialists (NSCLC/NMSC) and other key experts within assigned account alignment and deliver clinical messages to grow brand share and revenue.
- Facilitate partnership with multiple collaboration partners; Regional Director, Territory-based Oncology Account Specialists, OKALs (Oncology Key Account Leaders), Reimbursement Specialists to proactively resolve customer needs, identify market dynamics and trends, and develop strategies which support brand and corporate objectives in assigned territory.
- Develop strong working relationships with aligned designated accounts and specialists.
- Execute market profiling activities to ensure a deep understanding of regional and local health care delivery, influencers and payer systems.
- Proactively identify business opportunities with assigned accounts and leads appropriate coordination of effort by the Regeneron Oncology account team, e.g. supports contracting pull-through with accounts.
- Develop a breadth of relationships within each account to ensure an understanding of each account's objectives, goals, and challenges and identifies approved Regeneron Oncology resources that are aligned to the customer's needs.
- Demonstrates dedication to compliance through understanding of regulations and policies that govern customer interactions and consistent focus on ensuring compliance with them.
This role requires
- Bachelors degree; Master's degree or additional advanced education/certifications a plus
- Minimum 3 years successful experience in Oncology sales (NSCLC and/or NMSC experience Preferred)
- Buy and bill experience with biologics required
- Minimum of (3) years of experience working with key NSCLC/NMSC thought leaders or high influence customers in group practices, academic hospitals, key institutions
- Current account management experience in calling on large Oncology group practices and/or integrated delivery networks
- Strong understanding of the Oncology NSCLC/NMSC therapeutic area and the current Oncology marketplace
- Ability to collaborate with and coordinate activity among individuals in different reporting structures within the organization
- Passion and a learning aptitude for science and proactive in strengthening knowledge related to disease-state, treatment options and healthcare trends
- Must have ability to travel and cover large geography territories
Requirements
- Bachelors degree
- Minimum 3 years successful experience in Oncology sales
- Buy and bill experience with biologics required
- Minimum of 3 years of experience working with key NSCLC/NMSC thought leaders or high influence customers in group practices, academic hospitals, key institutions
- Current account management experience in calling on large Oncology group practices and/or integrated delivery networks
- Strong understanding of the Oncology NSCLC/NMSC therapeutic area and the current Oncology marketplace
- Ability to collaborate with and coordinate activity among individuals in different reporting structures within the organization
- Must have ability to travel and cover large geography territories
Benefits
- Health insurance
- Dental insurance
- Vision insurance
- Life insurance
- Disability insurance
- Fitness centers
- 401(k) company match
- Family support benefits
- Equity awards
- Annual bonuses
- Paid time off
- Military leave
- Parental leave
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.